Gutong Tiegao Pain Relieving

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with muscles and joints. Specifically, it is effective for conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be cleaned prior to application. The protective film must be removed from the patch, which should then be placed on the affected area, ensuring that the direction of stretch aligns with the joint action.

For adults and children aged 2 years and older, the patch may be applied to the affected area up to 3 to 4 times daily. For children under 2 years of age, it is recommended to consult a physician before use.

Contraindications

Use of this product is contraindicated in the following situations:

The product should not be applied to wounds, as this may impede healing and increase the risk of infection. Application to large areas of the body for extended periods is contraindicated due to the potential for systemic absorption and adverse effects. Additionally, the product must not be used on irritated or damaged skin, as this may exacerbate the condition or lead to further skin irritation. Finally, if there are any changes in the properties of the product, its use is contraindicated to ensure patient safety and efficacy.

Warnings and Precautions

For external use only. This product contains natural rubber latex, which may cause allergic reactions in susceptible individuals. Healthcare professionals should be aware of the potential for allergy and advise patients accordingly.

It is essential to avoid contact with the eyes or mucous membranes to prevent irritation. Bandaging should not be applied tightly, as this may lead to complications. Supervision is recommended when the product is used by children to ensure safety. Caution should be exercised in individuals with a history of allergies, and careful monitoring for hypersensitivity reactions, such as skin reactions, is advised. Additionally, the product should not be placed on extremely hairy areas of skin to minimize irritation during patch removal.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be instructed to discontinue use and consult a healthcare provider if any of the following occur: worsening of the condition, persistence of symptoms beyond 7 days, recurrence of symptoms after initial resolution, excessive skin irritation, or the onset of gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, or skin rash. For those using the product for arthritis-related pain, it is crucial to seek medical advice if pain persists for more than 10 days, if redness is observed, or if the product is being used in children under 12 years of age.

Side Effects

Patients using this product should be aware that it is for external use only. There is an allergy alert associated with this product, as it contains natural rubber latex, which may cause allergic reactions in some individuals.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if any of the following occur: the condition worsens; symptoms persist for more than 7 days; symptoms initially clear up but then recur within a few days; excessive skin irritation develops; or gastrointestinal symptoms such as nausea, vomiting, abdominal discomfort, diarrhea, or skin rash manifest.

Specifically, for patients using the product for arthritis-related pain, it is recommended to seek medical advice if pain persists for more than 10 days or if redness is present. Additionally, caution is advised when using this product in children under 12 years of age, and it is recommended to consult a doctor in such cases.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Gutong Tiegao Pain Relieving (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be supervised during the use of this medication. For adults and children aged 2 years and older, the recommended application is to the affected area no more than 3 to 4 times daily. For children under 2 years of age, it is advised to consult a physician prior to use.

In cases involving children under 12 years of age, if pain persists for more than 10 days or if redness is observed, the use of this medication should be discontinued, and a doctor should be consulted.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. There is limited data regarding the safety of this drug during pregnancy, and potential risks to fetal outcomes are not fully established. Women who are pregnant or nursing are advised to seek guidance from their doctor or pharmacist to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers should consult a doctor or pharmacist before using this medication, especially if they are taking other medications or are pregnant or nursing. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is advised when considering its use during lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure safety and therapeutic effectiveness.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can range from mild to severe and may include altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, intravenous fluids, and monitoring of vital parameters.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Consultation with a poison control center or toxicology expert may also be beneficial in managing the case effectively.

It is crucial to document all findings and interventions in the patient's medical record to ensure continuity of care and facilitate further management.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Serious side effects have been reported voluntarily through various channels, including surveillance programs. Healthcare professionals and patients are encouraged to report any serious adverse events to the designated contact number, (888) 221-3496, available Monday through Friday from 9 am to 5 pm.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental poisoning. In the event of ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed not to use the product on wounds, large areas of the body for extended periods, or on irritated or damaged skin. They should also be informed to discontinue use if the product's properties change.

Patients must be made aware to stop using the product and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms resolve and then recur within a few days. Additionally, they should seek medical advice if they experience excessive skin irritation, nausea, vomiting, abdominal discomfort, diarrhea, or a skin rash. For those using the product for arthritis pain, they should stop use and consult a doctor if pain persists for more than 10 days or if redness is present. Special caution should be taken when treating children under 12 years of age.

While using this product, patients should avoid contact with the eyes and mucous membranes, and they should not bandage the area tightly. Supervision is recommended for children using the product, and patients should exercise caution if they have a history of allergies. It is important for patients to check for hypersensitivity reactions and to avoid applying the product to extremely hairy areas of skin to prevent irritation during patch removal.

Patients should be encouraged to consult a doctor or pharmacist before using this product if they are taking other medications or if they are pregnant or nursing.

Storage and Handling

The product is supplied in a tightly sealed container to ensure its integrity. It should be stored at a temperature range of 8 to 30°C (46 to 86°F) and kept away from direct sunlight to maintain its efficacy. Proper handling and storage conditions are essential for preserving the quality of the product.

Additional Clinical Information

The transdermal route of administration is indicated for patients aged 2 years and older, with a recommended application frequency of 3 to 4 times daily to the affected area. For children under 2 years of age, it is advised to consult a physician prior to use. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Gutong Tiegao Pain Relieving, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)